Flow Cytometry in Invasive Endometrial Carcinoma
- 10 Downloads
The frequency of endometrial carcinoma is increasing world-wide, and in most countries in Western Europe and the United States, it is now the most common gynecologic malignancy. In Norway, endometrial carcinoma is the second most common cancer of the female genital tract. Approximately 500 new cases are anticipated in 1991, and about 120 will die of endometrial carcinoma every year in our country. More individualized therapy is probably essential in improving the prognosis for these high-risk patients .
Unable to display preview. Download preview PDF.
- 2.Di Saia P.J., Creasman W.T., Boronow R.C., Lessing J.A.: Risk factors and recurrent patterns in stage I endometrial cancer. Amer J Obstet Gynecol 151: 1009, 1985Google Scholar
- 4.Lindahl B., Aim O., Fernö M., Killander D., Längström E., Norgren A., Tropé C.: Prognostic value of flow cytometric DNA measurement in stage III endometrial carcinoma: Correlation with steroid receptor concentration, tumor myométrial invasion and degree of differentiation. Anticancer Research 7: 791, 1987PubMedGoogle Scholar